Detalhe da pesquisa
1.
Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancer.
Breast Cancer Res Treat
; 194(1): 57-64, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35471470
2.
Phase 1/2 Trial Results of a Large Surface Area Microparticle Docetaxel for the Treatment of High-Risk Nonmuscle-Invasive Bladder Cancer.
J Urol
; 208(4): 821-829, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35574612